The action being approved is the ability to solicit for DLA requirements on an Other Than Full and Open Competition basis in accordance with FAR 6.302-1.The supplies to be acquired are various types of Abbott Vascular cardiovascular products that fall into the following product categories: Atrial Fibrillation (AF), Coronary, Cardiac Rhythm Management (CRM), Endovascular, Heart Failure Management (HFM), Mechanical Circulatory Support (MCS), Neuromodulation Devices (NMD), and Structural Heart Devices (SHD).The proposed acquisition will result in a five-year Fixed Price Indefinite Delivery/Indefinite Quantity contract. Defense Logistics Agency (DLA) Troop Support, Medical Supplier Operations, is the contracting activity.